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Research
Arsenic is a ubiquitous element in the envi-
ronment, where it occurs in both organic and
inorganic forms; it can be found in food,
water, soil, and airborne particles, and
humans are widely exposed through these
sources (Tchounwou et al. 2004). Arsenic can
cause fatal acute poisoning, and long-term
exposure has been associated with various
cancers, diabetes, skin disease, chronic cough,
and toxic effects in the liver, kidney, cardio-
vascular system, and the peripheral and cen-
tral nervous systems (Vahter et al. 2006).
Organic arsenic, which is less harmful than
the inorganic forms, is most abundant in
food, whereas inorganic arsenic compounds
are found mainly in aquifers (Abernathy et al.
2003), where they accumulate by natural
processes such as weathering, erosion,
and biological activity, or eventually from
anthropogenic contamination (Smedley and
Kinniburgh 2005). Consequently, most
health-related problems associated with
arsenic are derived from groundwater used for
drinking (Farago et al. 1997; Smedley and
Kinniburgh 2005).
Epidemiologic studies in Asia (Chen et al.
1986, 1988; Tsuda et al. 1995; Wu et al.
1989) and Latin America (Ferreccio et al.
2000; Hopenhayn-Rich et al. 1996, 1998;
Marshall et al. 2007) have shown that high
arsenic concentrations (up to several hundred
micrograms per liter) in drinking-water are
associated with various internal cancers and
with cancer of the skin. Some of these studies
also provide evidence of a dose–response rela-
tion (Chen et al. 1986, 1988; Wu et al.
1989). However, few studies, most of which
were conducted in the United States, have
addressed the adverse effects of exposure to
low doses of arsenic, and their results are
inconsistent. Some showed a positive associa-
tion between relatively low doses of arsenic
and cancers of the skin, prostate, and bladder
(Knobeloch et al. 2006; Kurttio et al. 1999;
Lewis et al. 1999), whereas others showed no
such effects (Bates et al. 1995; Karagas et al.
2001; Steinmaus et al. 2003). One study
showed a nonsignificant decreasing risk for
bladder cancer with increasing exposure to
arsenic in the range of 3–60 µg/L (Lamm
et al. 2004), and Karagas et al. (2002) found
a U-shaped dose–response relation between
exposure to arsenic and non-melanoma skin
cancer, with a decreased risk at low levels and
increased risk at higher levels. The existence
of a threshold for the carcinogenic effect of
arsenic has been debated, especially in the
United States (Abernathy et al. 1996; Schoen
et al. 2004), and some studies have suggested
an interaction between exposure to arsenic
and smoking in the causation of cancers of
the lung, bladder and skin (Bates et al. 1995;
Ferreccio et al. 2000; Knobeloch et al. 2006;
Steinmaus et al. 2003; Tsuda et al. 1995).
Recent animal models for inorganic
arsenic carcinogenesis suggest that the carcino-
genicity of arsenic involves several mecha-
nisms and co-exposure to other carcinogens
(Burns et al. 2004; Cohen et al. 2007;
Rossman et al. 2004; Waalkes et al. 2007;
Wanibuchi et al. 2004). In vitro low concen-
trations of arsenic protected against oxidative
stress and DNA damage (Snow et al. 2005),
in accordance with the results of some of the
epidemiologic studies (Karagas et al. 2002;
Lamm et al. 2004). More studies are needed,
however, to evaluate the possible carcinogenic
effect of exposure to low concentrations of
arsenic. The aim of this large, population-
based cohort study was to determine if indi-
vidual exposure to low levels of arsenic in
drinking-water in Denmark is associated with
a risk for cancer.
Materials and Methods
Study population. The study was based on
the prospective Danish cohort Diet, Cancer
and Health, which has been described in
detail elsewhere (Tjønneland et al. 2007). In
brief, 160,725 persons 50–64 years of age
and living in one of 23 municipalities in the
Copenhagen or Aarhus area were invited to
participate. Of these, 57,053 persons (27,178
men and 29,875 women) accepted the invita-
tion and were enrolled between 1993 and
1997. At enrollment, information was col-
lected including on diet, beverages, smoking,
education, medical conditions, occupations,
reproductive factors, body mass index, and
skin reaction to sun. The study “Diet Cancer
and Health” has been approved by the rele-
vant Scientific Committees and the Danish
Data Protection Agency. Informed consent
was obtained from all participants to search
information from medical registers including
the Danish Cancer Registry. 
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BACKGROUND: Arsenic is a well-known carcinogen, which is often found in drinking-water.
Epidemiologic studies have shown increased cancer risks among individuals exposed to high con-
centrations of arsenic in drinking-water, whereas studies of the carcinogenic effect of low doses have
had inconsistent results. 
OBJECTIVE: Our aim was to determine if exposure to low levels of arsenic in drinking-water in
Denmark is associated with an increased risk for cancer.
METHODS: The study was based on a prospective Danish cohort of 57,053 persons in the
Copenhagen and Aarhus areas. Cancer cases were identiﬁed in the Danish Cancer Registry, and the
Danish civil registration system was used to trace and geocode residential addresses of the cohort
members. We used a geographic information system to link addresses with water supply areas, then
estimated individual exposure to arsenic using residential addresses back to 1970. Average exposure
for the cohort ranged between 0.05 and 25.3 µg/L (mean = 1.2 µg/L). Cox’s regression models were
used to analyze possible relationships between arsenic and cancer.
RESULTS: We found no signiﬁcant association between exposure to arsenic and risk for cancers of
the lung, bladder, liver, kidney, prostate, or colorectum, or melanoma skin cancer; however, the risk
for non-melanoma skin cancer decreased with increasing exposure (incidence rate ratio = 0.88/µg/L
average exposure; 95% confidence interval, 0.84–0.94). Results adjusted for enrollment area
showed no association with non-melanoma skin cancer. 
CONCLUSIONS: The results indicate that exposure to low doses of arsenic might be associated with a
reduced risk for skin cancer.
KEY WORDS: arsenic, cancer, cohort study, drinking-water, geographic information system. Environ
Health Perspect 116:231–237 (2008). doi:10.1289/ehp.10623 available via http://dx.doi.org/
[Online 23 November 2007]Since establishment of the Danish Central
Population Registry in 1968, all citizens of
Denmark have been given a unique personal
identiﬁcation number, which allows accurate
linkage among Danish registers. The cohort
members were followed up for cancer inci-
dence in the population-based Danish Cancer
Registry (Storm et al. 1997) from the time of
enrollment until the date of ﬁrst cancer diag-
nosis, emigration, death, or 1 August 2003,
whichever came ﬁrst. We included cancers of
the lung, bladder, liver, kidney, prostate,
female breast, and colorectum, and non-
melanoma and melanoma skin cancers. Only
ﬁrst cancers were included, although a case of
cancer was included even if it had been pre-
ceded by a non-melanoma skin cancer. 
Of the 57,053 cohort members, we
included 56,378 persons, who filled in the
lifestyle questionnaire, reported daily intake
of tap water, and had not had a cancer diag-
nosis before the enrollment. 
Residential histories. Using the personal
identification numbers of the cohort mem-
bers, we traced residential histories between
1970 and 2003 by record linkage to the
Central Population Registry. With this
method, we identified 202,339 unique
addresses, each with a unique identification
code composed of a municipality code, a road
code, and a house number. The date the per-
son had moved to and from the address was
noted. The addresses were then linked to a
database of all ofﬁcial addresses in Denmark,
resulting in geographic coordinates for
198,758 (98%) of the cohort addresses.
Subsequently, the addresses were mapped
with the ArcGIS 9.1 geographic information
system software (Environmental Systems
Research Institute, Inc., Redlands, California,
USA), and the proportion of addresses in
each of the 271 Danish municipalities was
calculated in relation to the total number of
geocoded cohort addresses (Figure 1). 
Water supply and arsenic measurements.
Arsenic concentrations in Danish drinking-
water were obtained from a database managed
by the Geological Survey of Denmark and
Greenland (Thomsen et al. 2004), which con-
tains the results of chemical tests in water utili-
ties in Denmark. Since 2001, it has been
compulsory for water utilities to measure
arsenic in the drinking-water and to report the
results to the database. The spatial locations of
the water utilities were determined by their
geographic coordinates, which were also regis-
tered in the database. We calculated the aver-
age arsenic concentration for each water utility
on the basis of 4,954 measurements in 2,487
water utilities reported between 1987 and
2004, with most measurements dating from
2002–2004. The average at each water utility
was assumed to represent arsenic concentra-
tions throughout the study period 1970–2003.
As drilling depth might affect arsenic concen-
trations and might have changed over time, we
collected data on the drilling depth and ana-
lyzed the correlation with the arsenic concen-
tration in drinking-water using Spearman’s
correlation coefﬁcient. 
To assess the effect of arsenic in drinking-
water on the risk for cancer among cohort
members, it was essential to link the arsenic
concentrations at the water utilities to each
address of the cohort members. Therefore,
information on the size and spatial location of
94 water supply areas was collected from local
authorities and water utilities in 24 municipali-
ties, covering the vast majority of the geocoded
cohort addresses. Seventy-one of the collected
water supply areas were supplied by only one
water utility, whereas the water in 23 areas
came from more than one utility. Therefore,
we also collected details of the volume of water
distributed from water utilities to these
23 areas to calculate water volume-weighted
average arsenic concentrations. If, for example,
an area received 40% of its water from one
utility and 60% from another, the arsenic con-
centration in the area would be calculated as
0.4 × concentration at utility1 + 0.6 × concen-
tration at utility2. The 94 water supply areas
were mapped in ArcGIS 9.1 (Figure 2) and
covered 84% of the cohort addresses. 
The geocoded cohort addresses, water utili-
ties, and water supply areas with their arsenic
concentrations were mapped in ArcGIS 9.1,
and arsenic concentrations were assigned to the
cohort members’ addresses, with the spatial
join functionality. First, the 170,403 (84%) of
the cohort addresses located within one of the
mapped water supply areas were assigned an
estimated arsenic concentration, by the “point-
in-polygon” procedure. This procedure allo-
cates the attributes of the polygon to all points
within it. Second, 28,355 (14%) of the
addresses were assigned the arsenic concentra-
tions of the nearest water utility, by application
of the “point-to-point”-spatial join. By this
procedure all points in one data set will be
given the attributes of the points in another
data set based on shortest distance. The last
3,581 (2%) of the cohort addresses had no
geographic reference and were allocated a
“missing value” as arsenic concentration. 
Arsenic exposure. We calculated two
exposures for each cohort member. The ﬁrst
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Figure 1. Distribution of geocoded cohort addresses
(n = 198,758) in 271 Danish municipalities. The pro-
portions are calculated as number of geocoded
cohort addresses in each municipality divided by
the total number of geocoded cohort addresses.
N
< 0.2
0.2–1.0
1.1–3.0
3.1–5.0
5.1–23.5
Percentage of geocoded cohort
addresses in Danish municipalities
0 25 50 km
Aarhus
Copenhagen
Figure 2. Ninety-four water supply areas classiﬁed according to estimated average arsenic concentration
(µg/L). These areas cover 84% of the 198,758 geocoded cohort addresses.
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(μg/L) in water supply areaswas a time-weighted average exposure, calcu-
lated as the arsenic concentration in drinking-
water multiplied by the time lived at each
address, summed for all residential addresses
during the study period and divided by the
total observation time, with the unit micro-
grams per liter (Equation 1).
Time-weighted average 
= (days1 × concentration1 + … + daysn
× concentrationn) ÷ (days1 + … + daysn). 
[1]
Second, we calculated the cumulated
arsenic exposure by cumulating the products
of “arsenic level × time” for each address
occupied during the total observation period
and multiplied by the total daily intake of tap
water, with the unit milligram (Equation 2).
The total daily intake of tap water was calcu-
lated as the sum of intake of tap water, coffee,
tea, and fruit syrup diluted with tap water,
which was reported at enrollment into
the cohort. 
Cumulated exposure 
= (days1 × concentration1 + … + daysn
× concentrationn) × intake of tap water, 
[2]
where n is the number of address periods.
Potential confounding factors. We used
data on smoking, alcohol consumption, edu-
cation, body mass index, daily intake of
fruit/vegetables, red meat, fat and dietary
ﬁbers, skin reaction to sun, hormone replace-
ment therapy use, reproduction, and occupa-
tion collected at enrollment into the cohort to
adjust for potential confounding factors for
each type of cancer. Further, data was ana-
lyzed both with and without adjustment for
enrollment area.
Statistical analyses. Statistical analyses
were carried out with the PHREG procedure
of SAS 8.2 software (SAS Institute Inc., Cary,
NC, USA). Cox proportional hazards models
were used to estimate incidence rate ratios
(IRRs) for cancer associated with the time-
weighted average and cumulative arsenic expo-
sure. Age was used as the time axis to ensure
that the estimates were based on comparisons
of individuals of the same age. The analyses
were corrected for delayed entry, so that indi-
viduals were considered at risk only from the
age at entry into the cohort. All analyses were
stratiﬁed by sex. The age of 41 years was cho-
sen as the starting point for calculating expo-
sure because the oldest person in the cohort
was 41 in 1970 when the residential histories
began. This ensured that the exposure assess-
ment started at the same age for all individu-
als. Both exposure measures—time-weighted
average exposure per micrograms per liter
since age 41 and total cumulated exposure per
5 mg since age 41—were included in the
model as time-dependent variables. Cohort
members were censored at age of death,
emigration, cancer diagnosis or if they had
moved to an address with unknown arsenic
concentration.
The associations between arsenic exposure
measures and cancer risk were modeled as
straight lines, and the analyses were adjusted
for known risk factors to control for potential
confounding. The linear assumption was eval-
uated with a linear spline (Greenland 1995),
with three boundaries placed at the quartiles of
the time-weighted average exposure at the time
of enrollment into the cohort. These were
included as covariates in the Cox model, and
linearity was assessed graphically and by a
numerical test. To evaluate linearity, we also
tested if an additional quadratic term improved
the model ﬁt. Further, we analyzed risk in asso-
ciation with quartiles of cumulated exposure at
the time of diagnosis for cancer cases to investi-
gate if the risk was higher or lower in associa-
tion with the highest exposures.
Analyses were repeated using time-
weighted average exposure to arsenic on the
basis of addresses occupied from 1970 for all
cohort members regardless of age. An addi-
tional analysis included a 5-year lag between
exposure and cancer diagnosis, that is, exclud-
ing the 5 years before the cancer diagnosis in
the exposure assessment of cases and a similar
period for the non-cancer cohort members.
We also repeated analyses after exclusion of
individuals who had lived at an address for
which the closest water utility was used as the
expected source of drinking-water.
Arsenic concentrations were generally
higher for persons enrolled in the Aarhus area
than those in the Copenhagen area. This
might imply confounding from risk factors
that were not accounted for that differed
between the Aarhus and the Copenhagen
areas. Therefore, we repeated analyses with
adjustment for enrollment area, knowing that
such adjustment limited the exposure con-
trasts evaluated in the analyses.
For initial analyses (without adjustment for
area) providing p-values ≤ 0.2, separate esti-
mates of the association with arsenic exposure
were calculated for the Aarhus and Copenhagen
enrollment areas by including an interaction
term in the model. This was to test the consis-
tency of the results. A persistent association in
both areas would strengthen the conﬁdence in
the result. We tested the null hypothesis that
the effect of arsenic exposure was the same in
the two areas (test for interaction).
On the basis of the results of previous
studies, the associations between exposure to
arsenic and cancers of the lung and bladder
and non-melanoma skin cancer were esti-
mated for never, former, and current smokers
separately, and we tested for different effects
of arsenic between the three smoking status
categories. 
Results
Demographic, dietary, occupational, and
other characteristics of the cohort members
are presented in Table 1.
The time-weighted arsenic exposure of
the cohort members calculated from 41 years
of age up to date of enrollment varied
between 0.05 and 25.3 µg/L, with a median
concentration of 0.7 µg/L and a mean con-
centration of 1.2 µg/L. The exposure was gen-
erally higher among those enrolled in Aarhus
than those enrolled in the Copenhagen area.
Aarhus: mean = 2.3 µg/L, median = 2.1 µg/L;
Copenhagen: mean = 0.7 µg/L, median =
0.6 µg/L (Table 2). 
Figure 3 illustrates a weak tendency
towards increasing drilling depth over the last
18 years. Drilling depth explained 4% of the
variation in arsenic concentration (R2 = 0.04;
n = 3,396). 
The results without adjustment for enroll-
ment area (Table 3) showed no significant
association between exposure to arsenic and
risk for any type of cancer, except for non-
melanoma skin cancer, for which higher
arsenic exposure was associated with lower
risk. The IRR for non-melanoma skin cancer
was 0.88 [95% confidence interval (CI),
0.84–0.94] per micrograms per liter increase in
time-weighted average exposure. A similar pat-
tern was seen for cumulated arsenic exposure,
with an IRR of 0.95 (95% CI, 0.92–0.97) for
a 5-mg increase in exposure. The risk estimates
for kidney cancer and melanoma were corre-
spondingly low for both exposure measures but
insigniﬁcant. Results adjusted for enrollment
area (Table 3) showed virtually no effect for
non-melanoma skin cancer, a stronger but still
insignificant inverse risk association for
melanoma skin cancer, and a significantly
increased risk for breast cancer in association
with time-weighted average exposure to arsenic
(IRR = 1.05; 95% CI, 1.01–1.10). 
Quartile-based analyses showed an IRR of
0.73 (95% CI, 0.59–0.91) for non-melanoma
skin cancer for the upper quartile compared
with the lower quartile of cumulated exposure
from 41 years of age to date of diagnosis, but
no decrease in risk was seen after adjustment
for enrollment area (IRR = 1.14). The similar
IRRs for melanoma skin cancer were 0.52
(95% CI, 0.28–0.98; p = 0.04) and 0.53 (95%
CI, 0.32–0.88; p = 0.01) with and without
adjustment for enrollment area respectively.
The risk did not differ significantly between
upper and lower quartile for any of the other
cancers regardless of adjustment for enrollment
area or not (all p > 0.12) (results not shown).
Spline and quadratic tests showed deviation
from a linear dose–response relation for cancers
of the breast, lung, prostate, and liver, and for
melanoma and non-melanoma skin cancers.
When evaluated graphically, the dose–response
relation for non-melanoma skin cancer showed
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ing trend that leveled off with increasing expo-
sure (Figure 4). The departure from linearity
appeared to be random and nonbiological for
the other cancers (results not shown).
In the overall analyses (Table 3, no adjust-
ment for area), the risk estimates were affected
to only a small extent by calculating time-
weighted average exposure to arsenic from
1970 for all cohort members regardless of age,
by introduction of a 5-year latency or by
exclusion of individuals for whom the closest
water utility was used as the expected source of
drinking-water at the residence (results not
shown). Furthermore, these results showed no
significant interaction between arsenic and
smoking, as the IRR estimates for never, for-
mer, and current smokers were not signifi-
cantly different for cancers of the lung or
bladder or non-melanoma skin cancer (all
p > 0.12) (results not shown). 
Table 4 shows inconsistent directions of
the risk association in the two enrollment areas
for non-melanoma skin cancer and a consistent
direction of the risk association (inverse) for
melanoma skin cancer, which was insigniﬁcant
for both enrollment areas. Further, a consistent
direction of the risk association for breast can-
cer (higher exposure was associated with higher
risk) was observed, which was statistically sig-
nificant in Aarhus when the time-weighted
average exposure measure was applied (IRR =
1.06; 95% CI, 1.0–1.11; p = 0.02). None of
the risk estimates differed signiﬁcantly between
the two areas (all p > 0.15).
Discussion
We found no increased risk for cancers
of the lung, bladder, kidney, liver, prostate,
and colorectum, and for melanoma and
non-melanoma skin cancers in association with
low levels of exposure to arsenic through drink-
ing-water. The risk for skin cancers decreased
with increasing exposure. Results adjusted for
enrollment area showed no significant risk
associations except for with breast cancer,
when the time-weighted average arsenic expo-
sure was used and for melanoma skin cancer in
the quartile-based analyses. 
The median and mean arsenic exposure at
enrollment were 0.7 and 1.2 µg/L, respec-
tively, which are comparable to the concentra-
tions found in Finland (median = 0.14 µg/L)
(Kurttio et al. 1999), and the United States
(mean = 2 µg/L) (Agency for Toxic Substances
and Disease Registry 2005) but much lower
than those found in some areas of Asia and
Latin America. 
Although previous studies provide evi-
dence for an etiologic relationship between
arsenic in drinking-water and cancer, they do
not predict the cancer risk of low doses
(Karagas et al. 2001). The arsenic levels in the
Danish drinking-water are 100–1,000 times
lower than those reported in studies from Asia
and Latin America. It is possible that arsenic
concentrations in the Danish drinking-water
are below a low effect level; however, the
results of the present study cannot rule out a
weak adverse effect that is impossible to detect
with the method used and the study size. 
Conﬂicting results have been obtained in
studies of arsenic and cancer conducted in
areas of low arsenic concentrations in drinking-
water. A Finnish case–cohort study reported
increased risk for bladder cancer in association
with exposure to arsenic (Kurttio et al. 1999)
based on 61 cases and significant only for
exposure 2–9 years before diagnosis for one of
the three exposure measures used (Kurttio et al.
1999). Interpretation of the ﬁnding is therefore
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Table 1. Demographic, lifestyle, and dietary characteristics of the cohort.
aAmong former and current smokers. bAmong ever alcohol drinkers. cAmong current and former users. dAmong mothers. eWaiter, cook. fMining, electroplating, manufacturing of
shoes/leather products, metal processing (welding/painting), foundry/steel rolling mill, shipyard, glass industry, building industry (roof constructor/asphalt worker/demolition worker),
truck/bus/taxi driver, manufacturing of asbestos/cement, asbestos insulation, cement article industry, china and pottery industry, butcher, painter, welder, auto mechanic, waiter, cook.
gHealth care. hRubber industry, textile industry (dyeing), metal processing (painting), glass industry, truck/bus/taxi driver, painter, hairdresser, waiter, cook. iBuilding industry (roof
constructor/asphalt worker).
Median
Characteristic No. (%) (5th–95th percentiles)
Total population  56,378 (100)
Sex
Male 26,876 (48)
Female 29,502 (52)
Age at inclusion (years) 56 (50–64)
Smoking
Status
Never 19,739 (35)
Former 16,231 (29)
Current 20,373 (36)
Missing data 35 (0)
Duration (years)a 33 (6–46)
Intensity (g tobacco/day)a 15 (4–35)
Alcohol
Status
Never 1,316 (2)
Ever 55,062 (98)
Intake (g/day)b 13 (1–65)
Education (years of school)
< 7 18,612 (33)
8–10 25,950 (46)
> 10 11,787 (21)
Missing data 29 (0)
Body mass index (kg/m2) 26 (20–33)
Dietary intake
Fruit and vegetables (g/day) 347 (108–803)
Fat (g/day) 81 (45–140)
Dietary ﬁber (g/day) 20 (11–34)
Red meat (g/day) 78 (32–166)
Tap water (L/day) 1.6 (0.7–2.9)
Median
Characteristic No. (%) (5th–95th percentiles)
Sun exposure
Skin reaction to sun
Very sunburnt 3,592 (6)
Sunburnt 8,689 (15)
Blushing followed by tanning 32,025 (57)
Sun tanned, no other reaction 11,918 (21)
Missing data 154 (0)
Sun tan during summer
Very 12,639 (22)
Moderately 31,817 (56)
Little 10,940 (19)
Not, only freckled  936 (2)
Missing data 46 (0)
Hormone replacement therapy
Never 16,045 (54)
Previously 4,569 (15)
Currently 8,852 (30)
Missing data 36 (0)
Years of usec 4 (0.5–18)
Births
None 3,542 (12)
Any 25,960 (88)
Numberd 2 (1–4)
Age at ﬁrstd 23 (18–32)
Ever occupied for at least 1 year in an industry 
or job associated with risk of developing:
Colorectal cancere 2,612 (5)
Liver cancere 2,612 (5)
Kidney cancere 2,612 (5)
Lung cancerf 15,866 (28)
Breast cancerg 6,636 (12)
Bladder cancerh 13,261 (24)
Non-melanoma skin canceri 697 (1)not straightforward. In contrast, our study,
based on 214 cases, showed no increased blad-
der cancer risk. In line with the results of our
study, the Finnish study did not ﬁnd an associ-
ation with kidney cancer (Kurttio et al. 1999).
Studies carried out in the United States found
no increased risk for bladder cancer with
increasing arsenic exposure (Bates et al. 1995;
Lamm et al. 2004; Steinmaus et al. 2003) in
areas with arsenic concentrations in drinking-
water of 0.5–160 µg/L. In one of these studies
an insignificant tendency toward decreasing
bladder cancer risk was seen with increasing
exposure to arsenic ranging from 3 to 60 µg/L
(Lamm et al. 2004). Another study in the
United States showed an increased risk for
prostate cancer in association with arsenic
exposure (Lewis et al. 1999). We did not ﬁnd
such an association.
In the present study, higher exposure to
arsenic was signiﬁcantly associated with a lower
risk for non-melanoma skin cancer in the over-
all analyses. Similar risk estimates were seen for
melanoma skin cancer, although the results
were not significant, possibly because of the
small number of cases. These ﬁndings conﬂict
with the results of some previous studies. In
Taiwan, Wu et al. (1989) found a signiﬁcant
dose–response relation for non-melanoma skin
cancer in association with exposure to arsenic,
and a study in the United States showed a
1.9 times higher risk for skin cancer (type not
speciﬁed) among persons exposed to drinking-
water containing > 10 µg/L arsenic than those
exposed to < 1.0 µg/L (Knobeloch et al. 2006).
Another study of exposure to low levels of
arsenic showed no association with non-
melanoma skin cancer (Karagas et al. 2001). In
a study of non-melanoma skin cancers in
which arsenic in toenail tissue was used as bio-
marker of exposure, a nonlinear dose–response
relation was seen with low exposures, with an
inverse association at low levels and an increas-
ing risk with concentrations > 0.09–0.11 µg/g
toenail, corresponding to 1–2 µg/L in drinking-
water (Karagas et al. 2002). This result is con-
sistent with our findings, as only a small
proportion of the cohort members were
exposed to drinking-water containing arsenic
at > 2 µg/L. 
In an experiment in cells in vitro a low dose
of arsenic had a protective effect against oxida-
tive stress and DNA damage, supporting the
hypothesis that low doses of arsenic could pro-
tect against cancer. In this study, the point, at
which the protective effect was out weighted
by the toxic effect was 1 µmol/L corresponding
to 50–60 µg/L (Snow et al. 2005). The ﬁnd-
ings of inverse risk associations for skin cancer
in the present study further support the
hypothesis that low doses of arsenic might be
inversely associated with risk for skin cancer. 
Nevertheless, the negative association
between arsenic and non-melanoma skin
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Table 3. Incidence rate ratios for cancer in association with arsenic exposure.
Further adjustment
Adjusted analysis for area of enrollment
Cancer No. of cases IRR 95% CI p-Value IRR 95% CI p-Value
Time-weighted average exposure (µg/L)
Colorectala 441 0.97 0.90–1.05 0.49 0.93 0.84–1.04 0.21
Liverb 35 1.05 0.88–1.25 0.57 0.97 0.72–1.29 0.81
Lungc 402 0.99 0.92–1.07 0.78 0.99 0.90–1.08 0.76
Breastd 766 1.03 0.99–1.08 0.20 1.05 1.01–1.10 0.02
Prostatee 332 1.03 0.97–1.09 0.41 1.03 0.96–1.10 0.45
Kidneyf 53 0.89 0.65–1.22 0.46 0.88 0.58–1.35 0.57
Bladderg 214 1.01 0.93–1.11 0.75 1.00 0.91–1.11 0.93
Melanoma skinh 147 0.89 0.73–1.07 0.20 0.80 0.59–1.08 0.14
Non-melanoma skini 1,010 0.88 0.81–0.94 0.0004 0.99 0.94–1.06 0.85
Cumulated exposure (5 mg)
Colorectala 441 0.98 0.96–1.01 0.28 0.97 0.93–1.01 0.10
Liverb 35 0.99 0.89–1.10 0.79 0.89 0.73–1.08 0.24
Lungc 402 1.0 0.98–1.02 0.80 1.00 0.98–1.03 0.75
Breastd 766 1.0 0.99–1.02 0.61 1.01 0.99–1.03 0.21
Prostatee 332 1.0 0.99–1.03 0.44 1.01 0.99–1.03 0.44
Kidneyf 53 0.94 0.84–1.06 0.33 0.94 0.81–1.09 0.38
Bladderg 214 1.0 0.98–1.04 0.55 1.01 0.98–1.04 0.69
Melanoma skinh 147 0.97 0.92–1.03 0.35 0.96 0.89–1.04 0.32
Non-melanoma skini 1,010 0.95 0.92–0.97 < 0.0001  0.99 0.97–1.01 0.35
aAdjusted for smoking status, smoking duration, smoking intensity, education, body mass index (BMI), alcohol status,
daily intake of alcohol, hormone replacement therapy (HRT) status, years of HRT use, occupation, daily intake of: red
meat, dietary ﬁbres, and fruits/vegetables. bAdjusted for smoking status, smoking duration, smoking intensity, education,
alcohol status, daily intake of alcohol, occupation. cAdjusted for smoking status, smoking duration, smoking intensity,
education, occupation, daily intake of fruits/vegetables. dAdjusted for HRT status, years of HRT use, no. of births, age at
ﬁrst birth, education, alcohol status, daily intake of alcohol, daily intake of fruits/vegetables, BMI, occupation. eAdjusted
for education, BMI, daily intake of: fruits/vegetables and fat. fAdjusted for smoking status, smoking duration, smoking
intensity, education, BMI, occupation. gAdjusted for smoking status, smoking duration, smoking intensity, education,
occupation. hAdjusted for education, skin reaction to sun, suntanned during summer. iAdjusted for education, skin reac-
tion to sun, suntanned during summer, occupation.
Table 2. Time-weighted average arsenic exposure from 41 years of age to date of enrollment.
Arsenic concentration (µg/L)
Percentile Entire cohort (n = 56,378) Enrolled in Copenhagen (n = 39,378) Enrolled in Aarhus (n = 17,000)
Minimum 0.05 0.05 0.09
1st 0.05 0.05 0.4
5th 0.3 0.05 0.8
25th 0.6 0.5 2.0
50th 0.7 0.6 2.1
75th 2.0 0.9 2.1
95th 2.1 2.0 2.5
99th 5.7 2.0 18.1
Maximum 25.3 15.8 25.3
Figure 3. Groundwater drilling depths as a function of time, based on 3,396 measurements from drillings
used for drinking-water.
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Yearcancer virtually disappeared when adjusted for
enrollment area and when separate risk esti-
mates were made for the two enrollment
areas. This might be interpreted as confound-
ing by some regional factor for which we did
not adjust. For example, exposure to the sun
is a risk factor for both melanoma and non-
melanoma skin cancer (Scotto et al. 1996),
and this might have confounded the results of
the overall analysis if such exposure was more
pronounced in the Copenhagen area, as the
arsenic concentrations in drinking-water were
generally higher in the Aarhus area. This
interpretation is, however, contradicted by
the fact that the inverse risk association for
melanoma skin cancer persisted when risk
estimates were calculated separately for the
two enrollment areas. Further, the lower risk
for confounding obtained by adjustment for
enrollment area might be counterbalanced
because this adjustment would make it more
difficult to detect any effect of arsenic expo-
sure, as part of the variation in exposure relates
to differences between the two enrollment
areas. Altogether, our ﬁnding of negative asso-
ciations between arsenic and non-melanoma
and melanoma skin cancers should be inter-
preted with caution.
To our knowledge, no epidemiologic
study of an association between arsenic and
cancer has included breast cancer. The
borderline significance of the finding of an
increased risk for breast cancer in association
with arsenic exposure among cohort members
enrolled in the Aarhus area should therefore
be interpreted with caution, and more studies
are needed to determine if arsenic in drink-
ing-water is a risk factor for breast cancer. 
Cases were identiﬁed in the virtually com-
plete, reliable nationwide Danish Cancer
Registry (Storm et al. 1997), and the Danish
Population Registry provided complete fol-
low-up of the cohort members. Although the
exposure of the cohort members was assessed
independently of who developed cancer, some
degree of nondifferential misclassification of
arsenic exposure inevitably occurred. This
would in most cases be expected to bias risk
estimates toward the neutral value (Rothman
2002), and it may therefore have contributed
to the null results of the present study.
Factors contributing to such exposure mis-
classiﬁcation include the following: a) Recent
arsenic measurement were assumed to repre-
sent historical exposure, in line with the
approach of other studies (Bates et al. 2004;
Kurttio et al. 1999). b) For 14% of the
addresses, we assumed that the nearest water
utility provided drinking-water to the address.
However, exclusion of persons, who had lived
at one of these addresses changed the risk esti-
mates only marginally. c) Some water utilities
might have closed during the study period,
and supply structures might have changed. It
is likely though that drinking-water from past
and present water utilities that are spatially
close would have similar arsenic concentra-
tions, as the geologic composition of aquifers
is fairly homogeneous over small geographic
areas. d) There is a lack of information about
exposure to arsenic through foodstuffs; how-
ever, arsenic in food occurs mainly in the less
harmful organic form, and the typical Danish
diet does not include arsenic-rich foods such
as seaweed, skate, or stingray (Mohri et al.
1990). e) There is uncertainty in the reported
intake of tap water. However, the results for
time-weighted average arsenic exposure would
not be affected by such misclassiﬁcation, and
the results for these two exposure measures
gave similar results. f) Use of domestic water
supply as a predictor for source of drinking-
water implies some uncertainty (Jones et al.
2006). Because most of the water supply areas
in the study covered large areas, such misclas-
siﬁcation would apply mainly to persons, who
traveled far between home and work.
Lack of information on residential histo-
ries before 1970 could also have led to mis-
classification of the exposure. Different
migration patterns for cases and noncases
before 1970 would imply differential misclas-
sification, but we consider this unlikely
because of the long time span between the
period of unknown migrations (before 1970)
and time of diagnosis for the cancer cases
(after inclusion between 1994 and 1997). 
The strengths of our study include the
large study population, the reliable popula-
tion-based Danish registers, and adjustment
for many potential confounding factors. Also,
the precise link between place of residence
and water supply and the measurements of
arsenic concentrations in the drinking-water
that was piped to the consumers adds strength
to the study.
The limitations of the study include the
overall low arsenic concentration in Danish
drinking-water and lack of information on
other sources of arsenic. Further, the exposure
of cohort members before 1970 could not be
estimated, as the residential histories before
that date were unknown. Therefore we were
Baastrup et al.
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Table 4. Incidence rate ratios for cancer in association with arsenic exposure in the two enrollment areas.
Time-weighted average exposure Cumulated exposure
Cancer No. of cases Area IRRa 95% CI p-Value IRRb 95% CI p-Value
Melanoma skinc 105 CPH 0.73 0.46–1.14 0.17 0.94 0.81–1.08 0.37
Melanoma skinc 42 ARH 0.85 0.61–1.20 0.36 0.97 0.90–1.05 0.47
Non-melanoma skind 813 CPH 1.09 0.95–1.24 0.21 1.01 0.97–1.06 0.66
Non-melanoma skind 197 ARH 0.97 0.90–1.05 0.46 0.98 0.95–1.01 0.22
Breaste 582 CPH 1.04 0.88–1.22 0.66 1.01 0.95–1.06 0.86
Breaste 184 ARH 1.06 1.01–1.11 0.02 1.01 0.99–1.03 0.20
Abbreviations: ARH, Aarhus enrollment area; CPH, Copenhagen enrollment area.
aPer µg/L time-weighted average arsenic exposure. bPer 5 mg cumulated arsenic exposure. cAdjusted for education, skin reaction to sun, sun tanned during summer. dAdjusted for
education, skin reaction to sun, sun tanned during summer, occupation. eAdjusted for hormone replacement therapy status and years of use, no. of births, age at ﬁrst birth, education,
alcohol status, daily intake of alcohol, daily intake of fruits/vegetables, body mass index, occupation.
Figure 4. Dose–response curve for non-melanoma skin cancer. Reference, IRR = 1 at average time-weighted
arsenic exposure of 0.05 µg/L.
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not able to assess early-life arsenic exposure,
which is an important limitation of this study
because early environmental exposures might
be most significant for cancer risk. Finally,
measurement of arsenic in nails or urine
would provide more precise estimates of the
personal exposure and should be included in
future studies whenever possible.
Conclusion
We found no statistical signiﬁcant association
between arsenic concentrations in Danish
drinking-water and the risk for cancers of the
lung, bladder, kidney, liver, prostate, or colo-
rectum. The results indicated inverse associa-
tions between arsenic concentrations in Danish
drinking-water and risk for skin cancers, sug-
gesting that arsenic might have a protective
effect at low concentrations. The results also
indicated that arsenic in drinking-water might
increase the risk for breast cancer. The ﬁndings
should be interpreted with caution, and more
studies are needed to conﬁrm the results.
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